Covestor's Ben Dickey is upbeat about Chesapeake's outlook. Strategies Ben Dickey: Chesapeake better off without McClendon
Aveo's Tivozanib kidney cancer drug will get the nod from regulators. Strategies Why Aveo’s Tivozanib should win FDA approval
Facebook's mobile strategy is starting to deliver. Strategies Five takeaways from Facebook’s Q1 earnings results